MALIGNANT INTRACRANIAL TUMOR
Clinical trials for MALIGNANT INTRACRANIAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT INTRACRANIAL TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT INTRACRANIAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam therapy shows promise in tumor control trial
Disease control CompletedThis study tested the Varian ProBeam proton therapy system in 47 people with solid tumors. The goal was to see if the device safely controls tumors and meets performance standards. Patients received proton radiation and were followed for up to 5 years after treatment.
Matched conditions: MALIGNANT INTRACRANIAL TUMOR
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New proton beam machine shows promise in tumor control trial
Disease control CompletedThis study tested a new proton therapy device, the Varian ProBeam360°, in 47 people with solid tumors. The goal was to see if it could control tumor growth with few severe side effects. Participants received radiation for 1 to 8 weeks and were followed for up to 5 years. The main…
Matched conditions: MALIGNANT INTRACRANIAL TUMOR
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC